Ga naar de hoofdinhoud
Top

Correction to: Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials)

  • Open Access
  • 09-01-2021
  • Correction
Gepubliceerd in:

Extract

The author of the article would like to add a video abstract as a supplementary material for a published article. The supplementary file is published with this correction. …
Titel
Correction to: Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials)
Auteurs
Véronique Crutel
Estelle Lambert
Pierre-François Penelaud
Cristina Albarrán Severo
Joaquin Fuentes
Antoine Rosier
Amaia Hervás
Stéphane Marret
Guiomar Oliveira
Mara Parellada
Simon Kyaga
Sylvie Gouttefangeas
Marianne Bertrand
Denis Ravel
Bruno Falissard
Publicatiedatum
09-01-2021
Uitgeverij
Springer US
Gepubliceerd in
Journal of Autism and Developmental Disorders / Uitgave 8/2021
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432
DOI
https://doi.org/10.1007/s10803-020-04822-8
Deze inhoud is alleen zichtbaar als je bent ingelogd en de juiste rechten hebt.